Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Apr 15 2016

Full Issue

Oncologist May Lose License After Allegedly Giving Cancer Patients Cheap, Imported Drugs

Ann Kinnealey, an Illinois oncologist, is accused of purchasing nearly $1 million worth of misbranded drugs over four years. In other news, a study finds that chemotherapy costs are higher when a patient's oncologist works for a health care system.

The Associated Press: Illinois Doctor Accused Of Importing Unapproved Cancer Drugs

An Illinois doctor may lose her license for allegedly putting unknowing patients at risk by giving them cheap, imported cancer drugs in violation of federal law. The Illinois Department of Financial and Professional Regulation temporarily suspended the medical license of Ann Kinnealey of Evanston last week. The state medical board is scheduled to hear the case April 21 in Chicago. (Johnson, 4/14)

Kaiser Health News: Rise In Oncologists Working For Hospitals Spurs Higher Chemo Costs: Study

If you have cancer, chances are your outpatient chemotherapy treatment costs are higher if your oncologist works for a health care system than if she has her own practice, a recent study found. The study by researchers at the University of Chicago analyzed private health insurance claims data from the Health Care Cost Institute, a nonprofit research organization, and national data about consolidation among doctors and hospitals between 2008 and 2013. It found significant consolidation between outpatient oncology practices and health care systems in the decade leading up to 2013. The researchers linked that to a rise in spending on drug-based cancer care. Each 1-percentage-point increase in the proportion of medical providers who were affiliated with a hospital or health system was associated with a 34 percent increase in annual average spending per person on outpatient cancer drug treatment, they reported. (Andrews, 4/15)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, July 15
  • Tuesday, July 14
  • Monday, July 13
  • Friday, July 10
  • Thursday, July 9
  • Wednesday, July 8
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF